Shares of Bio-Techne Corp. rose 3.75% to $61.40 Wednesday, on what proved to be an all-around favorable trading session for ...

Clear Street cut its price target to $7 from $93, saying KRRO-110 failed to reach protective protein levels in its Phase 1/2 ...

Investing.com -- Korro Bio Inc. (NASDAQ:KRRO) stock plummeted 80% after the company reported mixed results from its KRRO-110 clinical trial in Alpha-1 Antitrypsin Deficiency (AATD) patients.

Shares of Vor Bio declined after the company shared plans for a public offering of $100 million of its common stock. The stock fell 26% to $13.90 in after-hours trading on Monday. Shares are down 15% ...

J.P. Morgan, Jefferies, Citigroup and TD Cowen are acting as joint book-running managers for the offering.

Iovance has a long way to go to get to a break-even point, but the company has been showing progress. When a stock is in a ...

Now, it’s worth noting Stock Advisor’s total average return is 1,071 % — a market-crushing outperformance compared to 196% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

Nuvation Bio enrolled the first patient in a late-stage study of Ibtrozi. The bigger story, though, was a Wall Street analyst's initiation of coverage on the stock. Shares of Nuvation Bio (NYSE: NUVB) ...

Casdin Partners, a group that includes beneficial owners and entities related to Eli Casdin, reported purchasing shares of Standard BioTools INC (NASDAQ:LAB) between November 7 and November 12, 2025.

BIO-Key will provide VaporVM with its suite of security products, including the PortalGuard IAM platform, Passkey:YOU passwordless solution, PIN:You authentication method, and various biometric ...

Investing.com -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) stock surged 10% following the announcement of strategic agreements with Fidelion Diagnostics to commercialize VitaGuard, a liquid biopsy ...

J.P. Morgan, Jefferies, Citigroup and TD Cowen are acting as joint book-running managers for the proposed offering.